Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07126938 · ClinicalTrials.gov registry record
Alcohol Impairment Detection in Healthy Adult Users With the Gaize Device
A clinical trial, sponsored by Gaize.
- Completed
- Registry status
- 80
- Enrollment target
NCT07126938: Completed study, sponsored by Gaize.
NCT07126938 is a clinical trial that has completed, run by Gaize. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07126938 has completed, sponsored by Gaize.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
This study evaluates the effectiveness of the Gaize virtual reality headset as a non-invasive tool for detecting alcohol-related impairment through ophthalmic and neurological indicators. A total of 80 participants, evenly divided into an experimental (alcohol-consuming) and control (non-alcohol consuming) group, underwent baseline and post-consumption ocular assessments using the device. These assessments included: Lack of Smooth Pursuit, Horizontal Gaze Nystagmus at Maximum Deviation, Horizontal Gaze Nystagmus with Onset Prior to 45-Degrees, Vertical Gaze Nystagmus, Lack of Convergence, and Pupillary Rebound Dilation. The Gaize headset measured gaze vector and pupil size at 90 hertz per eye.
Primary Outcome
Number of participants and measurement of Lack of Smooth Pursuit, Horizontal Gaze Nystagmus at Maximum Deviation, Horizontal Gaze Nystagmus with Onset Prior to 45-Degrees, and Vertical Gaze Nystagmus were evaluated before and after alcohol consumption.
Interventions
- DRUG Alcoholic beverage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-03-21 |
| Est. Completion | 2024-11-22 |
What the finished NCT07126938 record still lists
NCT07126938 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Alcoholic beverage is the first listed.
NCT07126938 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07126938 about?
NCT07126938 is a clinical study titled "Alcohol Impairment Detection in Healthy Adult Users With the Gaize Device". This study evaluates the effectiveness of the Gaize virtual reality headset as a non-invasive tool for detecting alcohol-related impairment through ophthalmic and neurological indicators. A total of 80 participants, evenly divided into an experimental (alcohol-consuming) and control (non-alcohol con...
What is the current status of trial NCT07126938?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2024-03-21. Estimated completion is 2024-11-22.
What interventions are being tested in trial NCT07126938?
The interventions under investigation include: Alcoholic beverage (DRUG).
Who is sponsoring clinical trial NCT07126938?
This trial is sponsored by Gaize, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI